Syros Pharmaceuticals
SYRS
Reported
Thursday, March 2
Q4 2022 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.35 | -0.17 | 1.18 | 87.41% |
| Revenue | - | -754M | - | - |
WhatIF - Earnings
EPS Beat Expectations by $1.18
Syros Pharmaceuticals (SYRS:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything